BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 34496490)

  • 21. From Krukenberg to today: the ever present problems posed by metastatic tumors in the ovary. Part II.
    Young RH
    Adv Anat Pathol; 2007 May; 14(3):149-77. PubMed ID: 17452813
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mixed Müllerian Tumors of the Female Genital Tract.
    Soslow RA
    Surg Pathol Clin; 2009 Dec; 2(4):707-30. PubMed ID: 26838776
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Morphological and Immunohistochemical Reevaluation of Tumors Initially Diagnosed as Ovarian Endometrioid Carcinoma With Emphasis on High-grade Tumors.
    Lim D; Murali R; Murray MP; Veras E; Park KJ; Soslow RA
    Am J Surg Pathol; 2016 Mar; 40(3):302-12. PubMed ID: 26551621
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Uterine sarcoma: the Hacettepe hospital experience of 88 consecutive patients.
    Ayhan A; Tuncer ZS; Tanir M; Yüce K; Ayhan A
    Eur J Gynaecol Oncol; 1997; 18(2):146-8. PubMed ID: 9105869
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sarcomas metastatic to the ovary: a report of 21 cases.
    Young RH; Scully RE
    Int J Gynecol Pathol; 1990; 9(3):231-52. PubMed ID: 2373588
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Carcinosarcomas (malignant mixed Mullerian tumors) of the uterus. Morphology, pathogenetic aspects and prognostic factors].
    Horn LC; Dallacker M; Bilek K
    Pathologe; 2009 Jul; 30(4):292-301. PubMed ID: 19495763
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Infrequent loss of SMARCA4, SMARCA2, and SMARCB1 expression in uterine mesenchymal tumors.
    Kihara A; Amano Y; Matsubara D; Fukushima N; Fujiwara H; Niki T
    Hum Pathol; 2021 Oct; 116():12-21. PubMed ID: 34271067
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Undifferentiated Uterine Sarcomas Represent Under-Recognized High-grade Endometrial Stromal Sarcomas.
    Cotzia P; Benayed R; Mullaney K; Oliva E; Felix A; Ferreira J; Soslow RA; Antonescu CR; Ladanyi M; Chiang S
    Am J Surg Pathol; 2019 May; 43(5):662-669. PubMed ID: 30789359
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Uterine sarcoma: clinicopathological characteristics, treatment and outcome in Iran.
    Ghaemmaghami F; Karimi-Zarchi M; Gilani MM; Mousavi A; Behtash N; Ghasemi M
    Asian Pac J Cancer Prev; 2008; 9(3):421-6. PubMed ID: 18990014
    [TBL] [Abstract][Full Text] [Related]  

  • 30. How to approach the many faces of endometrioid carcinoma.
    Malpica A
    Mod Pathol; 2016 Jan; 29 Suppl 1():S29-44. PubMed ID: 26715172
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Uterine sarcomas express KIT protein but lack mutation(s) in exon 11 or 17 of c-KIT.
    Rushing RS; Shajahan S; Chendil D; Wilder JL; Pulliam J; Lee EY; Ueland FR; van Nagell JR; Ahmed MM; Lele SM
    Gynecol Oncol; 2003 Oct; 91(1):9-14. PubMed ID: 14529657
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular genetic changes in epithelial, stromal and mixed neoplasms of the endometrium.
    Lax SF
    Pathology; 2007 Feb; 39(1):46-54. PubMed ID: 17365822
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Sarcomas and mixed mesodermal tumors of the uterus].
    Günthert AR
    Ther Umsch; 2011 Oct; 68(10):559-64. PubMed ID: 21968895
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Endometrial carcinomas in women aged 40 years and younger: tumors associated with loss of DNA mismatch repair proteins comprise a distinct clinicopathologic subset.
    Garg K; Shih K; Barakat R; Zhou Q; Iasonos A; Soslow RA
    Am J Surg Pathol; 2009 Dec; 33(12):1869-77. PubMed ID: 19898223
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative clinicopathologic and immunohistochemical analysis of uterine sarcomas diagnosed using the World Health Organization classification system.
    D'Angelo E; Spagnoli LG; Prat J
    Hum Pathol; 2009 Nov; 40(11):1571-85. PubMed ID: 19540555
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunohistochemical survey of mismatch repair protein expression in uterine sarcomas and carcinosarcomas.
    Hoang LN; Ali RH; Lau S; Gilks CB; Lee CH
    Int J Gynecol Pathol; 2014 Sep; 33(5):483-91. PubMed ID: 25083964
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Primary endometrioid stromal sarcoma of the ovary: a clinicopathologic study of 27 cases with morphologic and behavioral features similar to those of uterine low-grade endometrial stromal sarcoma.
    Oliva E; Egger JF; Young RH
    Am J Surg Pathol; 2014 Mar; 38(3):305-15. PubMed ID: 24525500
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cervical and peritoneal fluid cytology of uterine sarcomas.
    Wang X; Khoo US; Xue WC; Cheung AN
    Acta Cytol; 2002; 46(3):465-9. PubMed ID: 12040638
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinicopathological Features Associated with Microsatellite Instability/Mismatch Repair Deficiency in Uterine Carcinosarcoma: A Quantitative Systematic Review.
    Travaglino A; Raffone A; Santoro A; Raimondo D; Orsini B; Casadio P; Zullo F; Seracchioli R; Zannoni GF; Insabato L; Mollo A
    Pathobiology; 2022; 89(4):198-204. PubMed ID: 35231921
    [TBL] [Abstract][Full Text] [Related]  

  • 40. BCOR Internal Tandem Duplication in High-grade Uterine Sarcomas.
    Mariño-Enriquez A; Lauria A; Przybyl J; Ng TL; Kowalewska M; Debiec-Rychter M; Ganesan R; Sumathi V; George S; McCluggage WG; Nucci MR; Lee CH; Fletcher JA
    Am J Surg Pathol; 2018 Mar; 42(3):335-341. PubMed ID: 29200103
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.